Skip to main content

Month: July 2020

Installux : nombre total de droits de vote et d’actions composant le capital social au 25 juin 2020

INSTALLUX S.A.Société Anonyme au capital de 4 564 576 eurosSiège social : Chemin du Bois Rond, 69720 SAINT BONNET DE MURE963 500 905 RCS LYON________________________Nombre total de Droits de vote et d’Actions composant le capital socialà la date de l’Assemblée Générale annuelle____________________________      Calculé conformément à l’article 223-11 du Règlement général de l’AMF, sur la base de l’ensemble des actions auxquelles sont attachés des droits de vote, y compris les actions privées de droit de vote, comme les actions auto-détenues ou autocontrôlées.      Après prise en compte des 146 actions auto détenues.                                                                               Le Conseil d’AdministrationPièce jointeINSTALLUX – information sur le nombre d’actions et de droits de vote au 25 juin 2020 – ...

Continue reading

Marie Brizard Wine & Spirits Monthly Declaration of the total nulber of voting rights and shares_June 2020

MONTHLY DECLARATION OF THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES(ARTICLE L233-8II THE COMMERCIAL CODE and 223-16 OF THE GENERAL REGULATIONS OF THE FINANCIAL MARKETS AUTHORITY (AMF))Paris, 10th  July, 2020MARIE BRIZARD WINE & SPIRITSISIN Code: 0000060873Do the Marie Brizard Wine & Spirits SA by-laws contain a clause requiring disclosure of the crossing of any statutory thresholds in addition to that relating to legal thresholds: yes.Including treasury sharesAfter deduction of treasury sharesAttachmentMBWS_MONTHLY DECLARATION OF THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES_June 2020

Continue reading

WSFS Financial Corporation Announces 2nd Quarter 2020 Earnings Release Date and Conference Call

WILMINGTON, Del., July 10, 2020 (GLOBE NEWSWIRE) — WSFS Financial Corporation (Nasdaq: WSFS), the parent company of WSFS Bank, expects to report its second quarter earnings report at the end of business Thursday, July 23, 2020.  Management will conduct a conference call to review this information at 1:00 p.m. Eastern Daylight Time (EDT) on Friday, July 24, 2020. Interested parties may listen to this call by dialing 1-877-312-5857 and using conference ID #3954236.A rebroadcast of the conference call will be available beginning at 4:00 p.m. EDT on July 24, 2020 until August 4, 2020 at 4:00 p.m. EDT, by dialing 1-855-859-2056 and using conference ID #3954236.About WSFS Financial CorporationWSFS Financial Corporation is a multi-billion-dollar financial services company. Its primary subsidiary, WSFS Bank, is the oldest and largest locally...

Continue reading

Volta Finance Limited: Net Asset Value as at 30 June 2020

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, IN WHOLE OR PART, IN OR INTO THE UNITED STATES*****Guernsey, 10 July 2020AXA IM has published the Volta Finance Limited (the “Company” or “Volta Finance” or “Volta”) monthly report for June. The full report is attached to this release and will be available on Volta’s website shortly (www.voltafinance.com).PERFORMANCE and PORTFOLIO ACTIVITYJune delivered another month of strong performance after May and April, helping further to recover the mark-to-market impact of the COVID-19 pandemic. Accounting for the €0.10 per share dividend paid 16th of June, Volta’s NAV* total return performance in June was +6.9%.With the increased confidence around cash flows from underlying assets over the medium term, not only was the Company able to restore the dividend ordinarily payable in April but has further...

Continue reading

Diabetic Foot Ulcer Treatment Market to reach USD 11.05 billion by 2027; Rising Adoption of Novel Wound Care Devices to Propel Growth: Fortune Business Insights™

Pune, July 10, 2020 (GLOBE NEWSWIRE) — The global diabetic foot ulcer treatment market size is projected to showcase remarkable growth on account of the increasing prevalence of diabetes followed by a foot ulcer. A diabetic foot ulcer is an open wound occurring in the sole of the feet of a diabetic person and requires immediate pressure, off-loading, infection control, and vasculature to heal.As per a recent report by Fortune Business Insights, titled, “Diabetic Foot Ulcer (DFU) Treatment Market Size, Share & Covid-19 Impact Analysis, By Ulcer Type (Neuropathic Ulcer, Ischemic Ulcer, Neuro-ischemic Ulcer), By Product (Wound-care Dressings, Wound-care Devices, Active Therapies, and Others), By End User (Hospitals, Clinics, Ambulatory Surgical Centers, and Homecare Settings), and Regional Forecast, 2020-2027,” the value of the...

Continue reading

CRCAM Alpes Provence : Déclarations_Hebdomadaires_CAAP_S28-2020

CAISSE REGIONALE DE CREDIT AGRICOLE MUTUEL ALPES PROVENCE                                                                                             Société coopérative à capital variable25, Chemin des trois cyprès 13097 Aix en Provence Cedex 2381 976 448 R.C.S Aix en ProvenceAix-en-Provence, le 10 juillet 2020Achats effectués dans les conditions de l’article 5 du règlement abus de marché dans le cadre du programme de rachat des Certificats Coopératifs d’Investissement autorisé par l’Assemblée Générale Mixte des sociétaires du 31 mars 2020.                                                                                             Le détail des transactions est disponible en annexe.Le Crédit Agricole Alpes Provence vous informe que le document est disponible sur son site Internet : http://www.ca-alpesprovence.fr et a été transmis...

Continue reading

Monthly information related to total number of voting rights and shares composing the share capital – June 30, 2020

LYON, France, July 10, 2020 (GLOBE NEWSWIRE) —Article 223-16 of general regulation of French Autorité des Marchés Financiers Lyon – FranceListing markets:Euronext Paris from Euronext (Market segment C –  ISIN Code: FR0011471135- Symbol: ERYP) &Nasdaq Global Select Market in the United-States (Symbol : ERYP)Website : www.erytech.com        (1) Gross voting rights number (or « theoretical » voting rights) is used as a basis for calculating the crossing of the threshold. In accordance with article 223-11 of general regulation of Autorité des Marchés Financiers, this number is calculated on the basis of all shares carrying the single and double voting rights, including shares without voting rights.(2) Without treasury shares.PDF available at: http://ml.globenewswire.com/Resource/Download/f5bb9638-d12d-4201-a19d-ad4739332...

Continue reading

Inventiva annonce la mise à disposition d’un prospectus dans le cadre de son offre au public d’actions ordinaires sous la formes d’ADS à l’occasion de son introduction en bourse sur le Nasdaq Global Market

Daix (France), le 10 juillet 2020 – Inventiva (Euronext Paris: IVA) (« Inventiva » ou la « Société »), société biopharmaceutique spécialisée dans le développement clinique de petites molécules administrées par voie orale pour le traitement de la stéatohépatite non alcoolique (« NASH »), des mucopolysaccharidoses (« MPS ») et d’autres maladies avec un besoin médical non satisfait significatif, annonce aujourd’hui que l’Autorité des marchés financiers (l’« AMF ») a approuvé un prospectus sous le n°20-338, le 10 juillet 2020, dans le cadre de son offre au public d’actions nouvelles sous la forme d’American Depositary Shares à l’occasion de son introduction en bourse sur le Nasdaq Global Market.Le prospectus est constitué:du document d’enregistrement universel déposé auprès de l’AMF le 19 juin 2020 sous le numéro D....

Continue reading

Résultats de l’exercice 2019-20

July 10, 2020 12:00 ET | Source: IVALIS    Informations Financières Montigny, le 10 juillet 2020 après bourse SA au capital de 262 097,20 € divisé en1 310 378 actions ordinaires et 108 actions de préférence   60, Avenue du Centre78180 Montigny le BretonneuxRCS Versailles B 381 503 531  Résultats de l’exercice 2019-20 – consolidés audités –   1.      Chiffre d’affairesEn K€ConsolidéExercice du 1er avril au 31 mars 2019-20 2018-19 Variation2019-20 vs 2018-19(en %) 2017-18 Variation2019-20 vs 2017-18(en %)CA du 1er semestre 28 301 29 219 -3,1% 29 623 -4,5%CA du 2ème semestre 44 569 48 435 -8,0% 47 258 -5,7%CA annuel consolidé 72 870 77 654 -6,2% 76 881 -5,2%Le chiffre d’affaires du groupe IVALIS s’élève à 72 870 K€ pour l’exercice 2019-20, en baisse de 6,2% par rapport à l’exercice 2018-19.L’activité...

Continue reading

MARE NOSTRUM – Bilan du contrat de liquidité au 30 juin 2020

MARE NOSTRUMBilan du contrat de liquidité au 30 juin 2020Grenoble, le 10 juillet 2020 – Au titre du contrat de liquidité portant sur les actions de la société Mare Nostrum, confié à TSAF, les moyens suivants figuraient au compte de liquidité à la date du 30/06/2020 :·Nombre d’actions : 7 300·Soldes en espèces : 18 312,76 €Au cours du 1er semestre 2020, il a été négocié un total de :Il est rappelé que lors du bilan semestriel du 31 décembre 2019, les moyens suivants figuraient au compte de liquidité :Nombre d’actions : 3 597Solde en espèces : 31 740 €Il est rappelé que lors de la mise en place du contrat de liquidité les moyens suivants ont été mis à disposition :Nombre d’actions : 0Solde en espèces : 50 000 €  A propos de Mare Nostrum :Depuis plus de 15 ans, le groupe Mare Nostrum est un expert innovant de la gestion des ressources humaines...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.